BELLUS Health Inc. BLU
14.75 0.00 (+0.00%)
Jun 28, 2023, 3:59 PM EDT
14.74 Day range 14.75
52-week range unavailable
Analyst view
Consensus: buy
Buy
Price target (mean) 16.05 +8.9% upside
Now 14.75
- Target (low)
- 14.75
- Target (mean)
- 16.05
- Target (high)
- 20.00
Ratings (-1m) 6 2 buy · 4 hold · 0 sell
- Strong buy0
- Buy2
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 6
- 2 months ago 7
- 3 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.24 | -0.24 – -0.24 | -0.18 | -33.3% | 0 | 0.0% | 1 |
| Next quarter | -0.26 | -0.26 – -0.26 | -0.20 | -30.0% | 0 | 0.0% | 1 |
| Current year | -0.88 | -0.88 – -0.88 | -0.66 | -33.3% | 0 | 0.0% | 1 |
| Next year | -1.19 | -1.19 – -1.19 | -0.88 | -35.2% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 15, 2023 | RBC Capital | Reiterated | Sector Perform | Sector Perform |
| Apr 19, 2023 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Apr 19, 2023 | Jefferies | Downgrade | Buy | Hold |
| Apr 18, 2023 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| Mar 22, 2023 | RBC Capital | Reiterated | — | Outperform |
| Mar 22, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Sep 30, 2022 | RBC Capital | Maintained | — | Outperform |
| Sep 23, 2022 | Jefferies | Maintained | — | Buy |
| Aug 11, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 13, 2022 | RBC Capital | Maintained | — | Outperform |
| Feb 24, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 13, 2021 | Evercore ISI Group | Maintained | — | Outperform |
| Dec 7, 2021 | RBC Capital | Maintained | — | Outperform |
| Oct 18, 2021 | RBC Capital | Maintained | — | Outperform |
| Sep 14, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 29, 2021 | BTIG | Initiated | — | Buy |
| Jan 29, 2021 | RBC Capital | Initiated | — | Outperform |
| Nov 25, 2020 | Jefferies | Initiated | — | Buy |
| Nov 18, 2020 | Evercore ISI Group | Initiated | — | Outperform |
| Aug 14, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 7, 2020 | Baird | Maintained | — | Outperform |
| Jul 7, 2020 | Guggenheim | Downgrade | Buy | Neutral |
| Jun 26, 2020 | HC Wainwright & Co. | Initiated | — | Buy |